Cardiovascular MRI for stem cell therapy

Current Cardiology Reports

Volumn 9, Issue 1, 2007, Pages 45-50

  Suzuki, Yoriyasu ^a   Yeung, Alan C ^a   Yang, Phillip C ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM CHELATE; GADOLINIUM PENTETATE; IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE;

ARTIFACT; BIOLOGICAL MONITORING; CARDIOVASCULAR MAGNETIC RESONANCE IMAGING; CELL DIFFERENTIATION; CELL LABELING; CLINICAL EFFECTIVENESS; COMPUTER; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEASIBILITY STUDY; FLUOROSCOPY; HEART FUNCTION; HUMAN; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; ISOTOPE LABELING; MESENCHYME CELL; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; RELIABILITY; REVIEW; SENSITIVITY ANALYSIS; STEM CELL TRANSPLANTATION; THREE DIMENSIONAL IMAGING;

ANIMALS; HEART FAILURE, CONGESTIVE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 34047262978     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-007-0009-6     Document Type: Review

References (50)

1. Emond M, Mock MB, Davis KB, et al.: Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 1994, 90:2645-2657.
2. Kramer CM, Lima JA, Reichek N, et al.: Regional differences in function within noninfarcted myocardium during left ventricular remodeling. Circulation 1993, 88:1279-1288.
3. Peters NS, Wit AL: Myocardial architecture and ventricular arrhythmogenesis. Circulation 1998, 97:1746-1754.
4. Orlic D, Kajstura J, Chimenti S, et al.: Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
5. Schachinger V, Assmus B, Britten MB, et al.: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOP-CARE-AMI Trial. J Am Coll Cardiol 2004, 44:1690-1699.
6. Wollert KC, Meyer GP, Lotz J, et al.: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364:141-148.
7. Arai T, Kofidis T, Bulte J, et al.: Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5 T. Magn Reson Med 2005, 55:203-209.
8. Fernandez-Aviles F, San Roman JA, Garcia-Frade J, et al.: Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004, 95:742-748.
9. Barbash IM, Chouraqui P, Baron J, et al.: Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003, 108:863-868.
10. MacLaren DC, Toyokuni T, Cherry SR, et al.: PET imaging of transgene expression. Biol Psychiatry 2000, 48:337-348.
11. Hofmann M, Wollert KC, Meyer GP, et al.: Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111:2198-2202.
12. Wu JC, Inubushi M, Sundaresan G, et al.: Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 2002, 106:180-183.
13. Wu JC, Chen IY, Sundaresan G, et al.: Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 2003, 108:1302-1305.
14. Himes N, Min JY, Lee R, et al.: In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction. Magn Reson Med 2004, 52:1214-1219.
15. Kraitchman DL, Heldman AW, Atalar E, et al.: In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003, 107-2290-2293.
16. Hill JM, Dick AJ, Raman VK, et al.: Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003, 108:1009-1014.
17. Tang Y, Shah K, Messerli SM, et al.: In vivo tracking of neural progenitor cell migration to glioblastomas. Hum Gene Ther 2003, 14:1247-1254.
18. Auerbach MA, Schoder H, Hoh C, et al.: Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 1999, 99:2921-2926.
19. Massoud TF, Gambhir SS: Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003, 17:545-580.
20. Rice BW, Cable MD, Nelson MB: In vivo imaging of light-emitting probes. J Biomed Opt 2001, 6:432-440.
21. Contag CH, Ross BD: It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imaging 2002, 16:378-387.
22. Remsen LG, McCormick Cl, Roman-Goldstein S, et al.: MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis. AJNR Am J Neuroradiol 1996, 17:411-418.
23. Pathak AP, Gimi B, Glunde K, et al.: Molecular and functional imaging of cancer: advances in MRI and MRS. Methods Enzymol 2004, 386:3-60.
24. Cranney G, Lotan C, Pohost G: Cardiovascular Applications of Magnetic Resonance Imaging. Edited by Pohost G, O'Rourke R. Boston: Little, Brown and Co.; 1991:503-528.
25. Bellenger NG, Burgess MI, Ray SG, et al.: Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance, are they interchangeable? Eur Heart J 2000, 21:1387-1396.
26. Mor-Avi V, Sugeng L, Weinert L, et al.: Fast measurement of left ventricular mass with real-time three-dimensional echocardiography: comparison with magnetic resonance imaging. Circulation 2004, 110:1814-1818.
27. Oe H, Hozumi T, Arai K, et al.: Comparison of accurate measurement of left ventricular mass in patients with hypertrophied hearts by real-time three-dimensional echocardiography versus magnetic resonance imaging. Am J Cardiol 2005, 95:1263-1267.
28. Kim RJ, Wu E, Rafael A, et al.: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445-1453.
29. Wu KC, Zerhouni EA, Judd RM, et al.: Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998, 97:765-772.
30. Gerber BL, Rochitte CE, Melin JA, et al.: Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 2000, 101:2734-2741.
31. Croisille P, Revel D, Saeed M: Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside. Eur Radiol 2006, 16:1951-1963.
32. Bulte J, Duncan I, Frank J: In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cere Blood Flow Metabol 2002, 22:899-907.
33. Frank JA, Miller BR, Arbab AS, et al.: Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003, 228:480-487.
34. Arbab AS, Yocum GT, Kalish H, et al.: Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004, 104:1217-1223.
35. Walczak P, Kedziorek DA, Gilad AA, et al.: Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 2005, 54:769-774.
36. Bulte JW, Douglas T, Witwer B, et al.: Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001, 19:1141-1147.
37. Kostura L, Kraitchman DL, Mackay AM, et al.: Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004, 17:513-517.
38. Aime S, Barge A, Cabella C, et al.: Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates. Curr Pharm Biotechnol 2004, 5:509-518.
39. Johnson KM, Tao JZ, Kennan RP, Gore JC: Gadolinium-bearing red cells as blood pool MRI contrast agents. Magn Reson Med 1998, 40:133-142.
40. Modo M, Cash D, Mellodew K, et al.: Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 2002, 17:803-811.
41. Cunningham CH, Arai T, Yang PC, et al.: Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005, 53:999-1005.
42. Stuber M, Gilson WD, Shah S, et al.: In-vivo cardiac IRON imaging of MR fluoroscopically delivered mesenchymal stem cells. Presented at the 14th annual proceedings of the International Society of Magnetic Resonance in Medicine. Seattle: May 6-12, 2006:1193.
43. Seppenwoolde J-H, Viergever MA, Bakker CJG: Passive tracking exploiting local signal conservation: the white marker phenomenon. Magn Reson Med 2003, 50:784-790.
44. Mani V, Briley-Saebo KC, Itskovich VV, et al.: Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn Reson Med 2006, 55:126-135.
45. Tse HF, Kwong YL, Chan JK, et al.: Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003, 361:47-49.
46. Perin EC, Silva GV, Sarmento-Leite R, et al.: Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation 2002, 106:957-961.
47. Zhang Q, Wendt M, Aschoff AJ, et al.: Active MR guidance of interventional. devices with target-navigation. Magn Reson Med 2000, 44:56-65.
48. Saeed M, Saloner D, Weber O, et al.: MRI in guiding and assessing intramyocardial therapy. Eur Radiol 2005, 15:851-863.
49. Dick AJ, Guttman MA, Raman VK, et al.: Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in Swine. Circulation 2003, 108:2899-2904.
50. Rickets C, Gallegos R, Seethamraju RT, et al.: Applications of magnetic resonance imaging for cardiac stem cell therapy. J Interv Cardiol 2004, 17:37-46.